Clinical trials
Type 2 diabetes clinical trials
A condition where the body can’t use insulin properly, raising blood sugar. We’re tracking 1,059 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06713720Recruiting
Arm Cuff Therapy for Early Diabetic Eye Disease
This study tests if a simple, non-invasive treatment called remote ischemic conditioning (briefly restricting blood flow to one arm using a special cuff) can help slow down early-stage diabetic eye disease in people with type 2 diabetes. You join the study to potentially prevent your retinopathy from getting worse.
Beijing, Beijing MunicipalityAges 40–80 - NCT06860516Recruiting
HLA Demographics Study in Adults With Type 1 Diabetes
This study (NCT06860516) is an observational trial of adults aged 18-55 with type 1 diabetes diagnosed within 6 months. It aims to collect demographic and HLA data.
San Francisco, CaliforniaAges 18–55 - NCT05203640Recruiting
Strength exercise study for post-menopausal type 1 diabetes
This study checks whether a resistance (strength) exercise program changes blood sugar levels in post-menopausal women with type 1 diabetes. You may be asked to do supervised lab-based exercise sessions near the University of Alberta.
Edmonton, AlbertaAges 45–75 - NCT06729242Recruiting
How menstrual cycle phases affect exercise and blood sugar in type 1 diabetes
This study looks at how the menstrual cycle changes the way your body responds to aerobic exercise or high-intensity interval training (HIIT) when you have type 1 diabetes. It may help you understand the best time to exercise for better blood sugar control.
Valencia, Select OneAges 18–45 - NCT06820281RecruitingPhase 2
Tirzepatide effects on metabolism in type 1 diabetes
This trial tests whether tirzepatide, a medication that helps control blood sugar and weight, can safely improve how your body handles sugar when you have type 1 diabetes. The study looks at short-term effects and may help people who are overweight and use an insulin pump or automated system.
Sydney, New South WalesAges 18–70 - NCT06784375Recruiting
Personalized diabetes education with a continuous glucose monitor
This study tests if a personalized education program, supported by continuous glucose monitor (CGM) wear, can help adults with type 2 diabetes improve their blood sugar control. Participants will receive extra training and a CGM device to see how food, activity, and medications affect their glucose levels in real time.
Minneapolis, MinnesotaAges 18 years+ - NCT06752928Recruiting
Comparing CGM to finger-stick glucose checks in hospitalized adults with type 1 diabetes
This study compares a continuous glucose monitor (CGM) to standard finger-stick blood sugar checks in adults with type 1 diabetes while they are in the hospital and after they go home. It aims to see if using a CGM leads to better blood sugar control during and after hospitalization.
Atlanta, GeorgiaAges 18 years+ - NCT06752369Recruiting
Online program for teens with type 1 diabetes and depression
This study tests a short online program to help teens with type 1 diabetes who feel down. It aims to see if a few sessions can improve mood and diabetes management.
Orlando, FloridaAges 12–17 - NCT06630585RecruitingPhase 3
Tirzepatide added to insulin pump for type 1 diabetes
This study tests whether adding a weekly injection of tirzepatide (a drug that helps with blood sugar and weight) can improve glucose control in adults with type 1 diabetes who already use an automated insulin pump. It may help you if your blood sugar is not at target despite using a pump.
Chêne-Bougeries, Canton of GenevaAges 18–65 - NCT06575842Recruiting
Accuracy of glucose monitors during surgery in youth with type 1 diabetes
This trial tests how well continuous glucose monitors (CGMs) work during surgery and hospital stays in young people with type 1 diabetes. It aims to make sure these devices give accurate readings when they are most needed.
Aurora, ColoradoAges 2–26 - NCT06524960RecruitingPhase 1/Phase 2
Denosumab for Preserving Insulin in Type 1 Diabetes
This study tests if denosumab, a drug normally used for bone health, can help preserve your body's own insulin production in type 1 diabetes. It might slow the loss of insulin-making cells, helping you maintain better blood sugar control over time.
Birmingham, AlabamaAges 18–50 - NCT06503809Recruiting
Ketogenic diet study for type 1 diabetes
This study tests if a very low-carb (ketogenic) diet is safe and helps control blood sugar in people with type 1 diabetes. You would follow the diet for a period and use a continuous glucose monitor to track your levels.
St Louis, MissouriAges 18–65 - NCT06435156RecruitingPhase 2
Sotagliflozin for Heart Failure in Type 1 Diabetes
This trial tests a medication called sotagliflozin for people who have both type 1 diabetes and heart failure symptoms. The goal is to see if it can improve how you feel and manage your heart and diabetes.
AberdeenAges 18–84 - NCT05977218Recruiting
Digital diabetes support through healthy eating habits
This trial tests whether a digital program can help people with type 2 diabetes improve healthy eating habits. It may help by supporting healthier food choices through an online system and goal-setting.
LinköpingAges 18–75 - NCT06273631Recruiting
Carbohydrate intake patterns for blood sugar control in type 1 diabetes
This study compares different ways of eating carbohydrates to see which pattern helps people with type 1 diabetes manage their blood sugar better. If you have type 1 diabetes and are on insulin, this trial might help you find an eating approach that improves your glucose control.
Nanjing, JiangsuAges 18–70 - NCT06144554Recruiting
Omnipod 5 pump study for type 1 diabetes
This study follows people with type 1 diabetes who are using the Omnipod 5 insulin pump. The goal is to understand how well the system works in everyday life by collecting data from your pump, continuous glucose monitor, and occasional home blood tests over one year.
Buffalo, New YorkAges 2 years+ - NCT05762107RecruitingPhase 2
Drug ZT-01 to reduce low blood sugar at night
This Phase 2 study tests ZT-01 to help prevent night-time low blood sugar (hypoglycemia) in people with type 1 diabetes. It may help if you’ve had low blood sugar during sleep or are at high risk based on recent glucose monitoring.
Birmingham, AlabamaAges 18–75 - NCT05653518Recruiting
Artificial pancreas therapy to steady sugars and protect the heart
This study tests an “artificial pancreas” system that automatically helps control insulin to reduce wide swings in blood sugar. It also aims to see whether steadier sugars can improve heart health in adults with type 1 diabetes.
Charlottesville, VirginiaAges 18–40 - NCT05641753RecruitingPhase 4
LDL-lowering study for adults with type 1 diabetes
This study looks at cholesterol lowering in adults with type 1 diabetes and whether it reduces “residual risk,” meaning risk that may remain even with current care. You may be asked to take cholesterol-focused treatment and complete blood tests to track LDL (“bad cholesterol”).
New York, New YorkAges 18–89 - NCT05594706Recruiting
Anhydroglucitol test in children with type 1 diabetes
This trial studies how anhydroglucitol behaves in children with type 1 diabetes who use insulin pump therapy and glucose monitoring. Your team will compare measurements over about a year to see if this marker could be useful for tracking diabetes control.
Geneva, Canton of GenevaAges 2–18 - NCT05478707RecruitingPhase 2
Treating small blood vessel problems in type 1 diabetes
This study tests whether two different treatment strategies can improve the function of the tiny blood vessels in people with type 1 diabetes. It aims to find a way to prevent or reduce diabetes-related complications.
Orlando, FloridaAges 18–40 - NCT05317455RecruitingEarly Phase 1
Studying brain sugar changes in adults with risky low blood sugar
This early-stage study looks at how the brain uses sugar in people with type 1 diabetes who have had severe or hard-to-notice low blood sugar. It may help researchers understand the brain effects of low blood sugar and guide safer care.
New Haven, ConnecticutAges 18–55 - NCT05139784Recruiting
Study of immune changes in people with type 1 diabetes and other diabetes
This study looks at immune (defense system) and blood-sugar changes in people with type 1 diabetes, and in some other diabetes or autoimmune hormone conditions. It includes people who will have a specific abdominal surgery so doctors can safely study lymph node tissue.
Bobigny, Île-de-France RegionAges 1 year+ - NCT05153070RecruitingPhase 2
Cyclosporine then low-dose immune therapy for new type 1 diabetes
This Phase 2 study tests whether starting with cyclosporine and then giving low-dose IL-2 can better protect the body’s insulin-producing function after type 1 diabetes is diagnosed. It’s meant for people diagnosed very recently who have specific diabetes-related immune markers.
ParisAges 16–45
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for type 2 diabetes?
- Yes. Clin2 currently lists 1,059 recruiting type 2 diabetes studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a type 2 diabetes trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a type 2 diabetes trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.